Cleared Traditional

Tablet Application

K203566 · Smith & Nephew · General & Plastic Surgery
May 2021
Decision
157d
Days
Class 2
Risk

About This 510(k) Submission

K203566 is an FDA 510(k) clearance for the Tablet Application, a Endoscopic Central Control Unit (Class II — Special Controls, product code ODA), submitted by Smith & Nephew (Andover, US). The FDA issued a Cleared decision on May 13, 2021, 157 days after receiving the submission on December 7, 2020. This device falls under the General & Plastic Surgery review panel. Regulated under 21 CFR 876.1500.

Submission Details

510(k) Number K203566 FDA.gov
FDA Decision Cleared SESE
Date Received December 07, 2020
Decision Date May 13, 2021
Days to Decision 157 days
Submission Type Traditional
Review Panel General & Plastic Surgery (SU)
Summary Summary PDF

Device Classification

Product Code ODA — Endoscopic Central Control Unit
Device Class Class II — Special Controls
CFR Regulation 21 CFR 876.1500
Definition To Control Endoscopic And Other Ancillary Surgical Equipment In One Central Location, Either By Remote Control, Touch Screen, Or Voice Command.

Similar Devices — ODA Endoscopic Central Control Unit

All 17
KARL STORZ OR1? SCB CONTROL (WU300)
K232406 · Karl Storz SE & CO. KG · Oct 2023
Smith+Nephew INTELLIO Tablet
K221929 · Smith & Nephew · Sep 2022
INTELLIO Tablet Application
K192876 · Smith & Nephew · Feb 2020
IDSS ForceTriad Control Module
K153205 · Black Diamond Video, Inc. · Aug 2016
core nova Complete Operating Room Endoscopy
K151282 · Richard Wolf Medical Instruments Corp. · Jan 2016
KARL STORZ SCB / COVIDIEN FORCETRIAD INTERFACE MODULE
K111165 · KARL STORZ Endoscopy-America, Inc. · Jan 2012